Descemet Stripping (Automated) Endothelial Keratoplasty (DSEK or DSAEK)
This study is currently recruiting participants.
Verified February 2009 by Netherlands Institute for Innovative Ocular Surgery
Sponsor:
Netherlands Institute for Innovative Ocular Surgery
Collaborators:
Amnitrans Eyebank Rotterdam
Melles CorneaClinic Rotterdam
Information provided by:
Netherlands Institute for Innovative Ocular Surgery
ClinicalTrials.gov Identifier:
NCT00543660
First received: October 11, 2007
Last updated: February 3, 2009
Last verified: February 2009
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
To evaluate the transplantation of a posterior corneal disc for the management of corneal endothelial disorders in Descemet Stripping Endothelial Keratoplasty (DSEK) or Descemet Stripping Automated Endothelial Keratoplasty (DSAEK).
| Condition | Intervention |
|---|---|
|
Corneal Dystrophies, Hereditary |
Procedure: Descemet Stripping Automated Endothelial Keratoplasty (DSAEK) |
| Study Type: | Interventional |
| Study Design: | Endpoint Classification: Efficacy Study Intervention Model: Single Group Assignment Masking: Open Label Primary Purpose: Treatment |
Resource links provided by NLM:
Genetics Home Reference related topics:
lattice corneal dystrophy type I
Lenz microphthalmia syndrome
oculofaciocardiodental syndrome
Peters plus syndrome
U.S. FDA Resources
Further study details as provided by Netherlands Institute for Innovative Ocular Surgery:
Primary Outcome Measures:
- Best spectacle corrected visual acuity [ Time Frame: 1998 - 2018 ] [ Designated as safety issue: No ]
Secondary Outcome Measures:
- Corneal endothelial cell density [ Time Frame: 1998-2018 ] [ Designated as safety issue: No ]
| Estimated Enrollment: | 1000 |
| Study Start Date: | March 1998 |
| Estimated Study Completion Date: | March 2018 |
| Estimated Primary Completion Date: | March 2018 (Final data collection date for primary outcome measure) |
Intervention Details:
Detailed Description:
-
Procedure: Descemet Stripping Automated Endothelial Keratoplasty (DSAEK)
- Descemet Stripping Endothelial Keratoplasty (DSEK)
- Descemet Stripping Automated Endothelial Keratoplasty (DSAEK)
- Please see www.niios.com
Other Names:
Please see above.
Eligibility| Ages Eligible for Study: | 21 Years and older |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
Criteria
Inclusion Criteria:
- Corneal endothelial disorders
Exclusion Criteria:
- N/A
Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00543660
Contacts
| Contact: Gerrit RJ Melles, MD PhD | 31 10 297 4444 | melles@niioc.nl |
| Contact: Kim Herders, MSc | 31 10 297 4444 | herders@niios.com |
Locations
| Netherlands | |
| Netherlands Institute for Innovative Ocular Surgery | Recruiting |
| Rotterdam, Netherlands, 3071 AA | |
| Contact: Kim Herders, MSc 31 10 297 4444 herders@niios.com | |
| Sub-Investigator: Lisanne Ham, MSc | |
| Sub-Investigator: Jacqueline van der Wees, PhD | |
| Principal Investigator: Gerrit RJ Melles, MD PhD | |
Sponsors and Collaborators
Netherlands Institute for Innovative Ocular Surgery
Amnitrans Eyebank Rotterdam
Melles CorneaClinic Rotterdam
Investigators
| Principal Investigator: | Gerrit RJ Melles, MD PhD | Netherlands Institute for Innovative Ocular Surgery |
More Information
Additional Information:
Publications:
| Responsible Party: | G. Melles, NIIOS |
| ClinicalTrials.gov Identifier: | NCT00543660 History of Changes |
| Other Study ID Numbers: | NIIOS.1998.04 |
| Study First Received: | October 11, 2007 |
| Last Updated: | February 3, 2009 |
| Health Authority: | Netherlands: Independent Ethics Committee |
Keywords provided by Netherlands Institute for Innovative Ocular Surgery:
|
Corneal transplantation, Descemet membrane, endothelium |
Additional relevant MeSH terms:
|
Corneal Dystrophies, Hereditary Corneal Diseases Eye Diseases Eye Diseases, Hereditary Genetic Diseases, Inborn |
ClinicalTrials.gov processed this record on May 19, 2013